chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site haemorrhage
Clinical narrative: did have a lot of bleeding at the injection site in the left arm and they may have hit a blood vessel after she was administered the Prevnar 13; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration, in left arm, in Feb2020 (Batch/Lot number was not reported) as unknown dose, single for immunization. The patient medical history and concomitant medications were none. The patient had the pneumococcal 13-val conj vac last year which was a year ago in Feb2020 and she did not have a problem with it but did have a lot of bleeding at the injection site in the left arm and they may have hit a blood vessel after she was administered the pneumococcal 13-val conj vac. Caller states the date she had bleeding at the injection site after being administered pneumococcal 13-val conj vac was she thinks but is not positive and would have to find out on her calendar but thinks it was on 27Feb2020; states she also has the date on her calendar for receiving the pneumococcal 13-val conj vac is also on 28Feb2020 so it is sometime around then when this occurred. She wonder if the pneumococcal 13-val conj vac she got last year was on 27Feb2020 or earlier but it was definitely in Feb2020. Caller states she is not really sure how long the bleeding at the injection lasted and it maybe lasted for 5 minutes; caller states they did not expect the bleeding at the injection site to happen and had to go get some tissue to try to help clean it up; caller states the bleeding at the injection site resolved the same day she thinks and the best she can remember and the only thing she remembers is that maybe they hit a blood vessel but does not know if that happened and she has no idea. Caller states the formulation and dosage are known for the pneumococcal 13-val conj vac; states they did not draw up the vaccine in front of her but that was done in a little room and they came in the room with her with a needle already on the syringe and the syringe was prefilled; caller states she does not know if they filled the syringe themselves or not. The outcome of the event was recovered in Feb2020  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present, Depressed mood, Fatigue
Clinical narrative: Urinating blood; very depressed; tired for one week; This is a spontaneous report from a contactable consumer or other non hcp. A 65-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on 27Feb2021 10:00 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history was unknown. The patient's concomitant medications were not reported. On 06Mar2021 06:00, the patient experienced urinating blood and very depressed and tired for one week. The treatment received for events was unknown. The outcome of the events recovered.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Rash macular, Skin irritation
Clinical narrative: Red irritation in lateral area of left arm, forehead, nose and lateral nose area, with little red spots in front and lateral area of nose; Red irritation in lateral area of left arm, forehead, nose and lateral nose area, with little red spots in front and lateral area of nose.; Red irritation in lateral area of left arm, forehead, nose and lateral nose area, with little red spots in front and lateral area of nose; This is a spontaneous report from a contactable consumer (patient herself). A 70-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: 6N6198; Expiry date: unknown) via an unspecified route of administration, administered in Arm Left on 02Mar2021 13:30 as single dose for COVID-19 immunization. The patient medical history was not reported. The patient's other medical history was reported as none. Patient had not any allergies to medications, food, or other products. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included ezetimibe, simvastatin (VYTORIN) and collagen (COLLAGEN) taken for an unspecified indication. On 03Mar2021 patient experienced Red irritation in lateral area of left arm, forehead, nose and lateral nose area, with little red spots in front and lateral area of nose. Therapeutic measures were taken as a result of Red irritation in lateral area of left arm, forehead, nose and lateral nose area, with little red spots in front and lateral area of nose allegra was taken as treatment by the patient. The patient was not diagnosed prior and since the vaccination with COVID-19. The clinical outcome of event was recovering.    No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: FLUX, PPV
Symptoms: Peripheral swelling
Clinical narrative: her right arm did get swollen; This is a spontaneous report from a contactable consumer (patient). An elderly female patient received pneumococcal 13-val conj vac (dipht crm197 protein), via an unspecified route of administration, administered in right arm on an unspecified date (Batch/Lot number was not reported) as single dose for immunisation; influenza vaccine (FLU), via an unspecified route of administration on the same date, at unspecified dose for immunisation. Patient's Medical History (including any illness at time of vaccination): None. The patient's concomitant medications were not reported. Other Products: No. The patient experienced her right arm did get swollen on an unspecified date with outcome of unknown.  About 2 years ago, she got a pneumonia booster and a flu vaccine on the same day, both in the right arm, and her right arm did get swollen. List other relevant diagnostic and confirmatory test results for event: None. Investigation Assessment: No. The patient didn't take any medications for it, but did take supplements.  Company is a marketing authorization holder of pneumococcal 13-val conj vac (dipht crm197 protein) in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of pneumococcal 13-val conj vac (dipht crm197 protein) has submitted the same report to the regulatory authorities.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Nausea, Pain in extremity
Clinical narrative: Arm sore; Joint pain all over my body; Bad headache; Nauseated; This is a spontaneous report from a contactable consumer or other non hcp (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EN6199), via an unspecified route of administration on an unspecified date as 2nd dose, single for COVID-19 immunization. The patient medical history was not reported. Concomitant was not reported. On an unspecified date, the patient reported that she had Pfizer shot yesterday at 9:00 o'clock and she did not felt that day and later in the evening at 8:00 o'clock, her arm was really sore and she continued to have joint pain all over the body and had a bad headache and nauseated. She wanted to know that she can take Anacin or Tylenol or Dramamine because she got a bad headache and nauseated. When probed for vaccine details, consumer stated, "The one we got yesterday. I am 86 and I don't know why I am feeling like this (headache and nauseated). My husband was trying to help me here. We both got this one but he has a joint pain but now I have (incomplete sentence). They gave 2 little card and they said come back the 26th of this month. All I see on this just little card. (name) , I don't know what else is here, it says CBC in the corner. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: soreness; Injection site soreness; This is a spontaneous report from a contactable consumer (patient) reported for self. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 01Mar2021 15:25 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced soreness (non-serious) on 01Mar2021 17:25, injection site soreness (non-serious) on 01Mar2021. Patient wanted to report that after receiving the COVID-19 vaccine dose 1 at the (name), patient have experienced soreness around the injection site. This started about a two hours after injection (3:25 pm Monday, 01Mar2021) and has persisted. Product: Covid-19 Vaccine. Symptom: Injection site soreness. For events, soreness, outcome was not recovered, injection site soreness, outcome was unknown.   No follow up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Cough, Feeling hot, Malaise, Product dose omission issue, Wheezing
Clinical narrative: they missed their 2nd shot of vaccine on 3/30/2021 along with his; I don't feel well; Wheezing; I feel warm but I don't know the temperature according to my thermometer and I don't feel well; Coughing; This is a spontaneous report from a contactable consumer (patient) reporting himself. A male patient of an unspecified age received first dose of bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 09Mar2021 as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date patient stated, "I think I am having some kind of side effect and for like wheezing like and coughing and I feel warm, but I don't know the temperature according to my thermometer and I don't feel well, I had the shot (COVID 19 Vaccine by Pfizer) on Friday and each day its worse and worse. Upon follow-up on 08Apr2021, it was reported that, called to advise they missed their 2nd shot of vaccine on 30Mar2021 along with his wife and his wife received the 1st shot on 9Mar2021. However, his wife was hospitalized due to kidney infection from March 24th to March 26th and they were in the hospital the whole week, mentioned that his wife was already out of the hospital and he is trying to figure out where to get their 2nd shot of covid vaccine since they've missed it. The outcome of the event was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Headache, Muscle injury, SARS-CoV-2 test
Clinical narrative: soreness; headache; bilateral hamstring muscle pain; This is spontaneous report from a contactable other Health Care Professional via Pfizer sponsored program. A 70-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: Unknown), via unspecified route of administration on 26Jan2021, as a single for COVID-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: Unknown), via unspecified route of administration on 05Jan2021, as a single for COVID-19 immunization. The patient's medical history included Chronic Lymphocytic Leukemia and some particular type of anemia. She received IVIG treatment every 30-32 days. Concomitant medications included Intravenous Immunoglobulin (IVIG) treatment every 30-32 days. On an unknown date, the patient experienced bilateral hamstring muscle pain, soreness and headache. On 26Feb2021, the patient underwent blood test to detect antibodies against COVID infection and the result was negative. The Reporter wanted to know what are all the other tests they can do and also stated that he heard that muscle pain has been reported 38% post vaccination. He wanted to know if muscle pain can progress to myalgia. No patient identifiers were provided but the reporter has firsthand knowledge of the patient and was reporting on a specific patient. It was reported that antibodies in some persons can be detected within the first week of illness onset. In SARS-CoV-2 infections, Immunoglobulin M and Immunoglobulin G antibodies can arise nearly simultaneously in serum within 2 to 3 weeks after illness onset. Thus, detection of IgM without IgG is uncommon. How long IgM and IgG antibodies remain detectable following infection was not known. It was also important to note that some persons do not develop detectable IgG or IgM antibodies following infection. Thus, the absence of detectable IgM or IgG antibodies does not necessarily rule out that they could have previously been infected. The outcome of the events was unknown.  No follow-up attempts are possible. No information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: chills; headache; fatigue; This is a spontaneous report from a contactable consumer (patient) via Pfizer sales representative. A 41-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiry date not reported) as unknown, single for COVID-19 immunization. Medical history was not reported. Concomitant medications were none. On an unspecified date, the patient experienced chills, headache and fatigue. Clinical outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; achy all over; little temperature; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Mar2021 (Batch/Lot number and Expiry date not reported) as unknown, single for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient experienced sore arm on an unspecified date with outcome of unknown, achy all over on an unspecified date with outcome of unknown, and little temperature on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included body temperature: little temperature on an unspecified date. The events were reported as non-serious.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Painful respiration
Clinical narrative: pain on his arm; heart ache during deep breath; This is a spontaneous report from a contactable consumer received via a male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 03Mar2021 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 04Mar2021, the patient experienced pain on his arm and heart ache during deep breath. The patient was not treated for the events. The outcome of the event was unknown.  No follow-up attempts are possible; information about batch number cannot be obtained.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Myalgia
Clinical narrative: Since increase in Pristiq having pain in left gluteal muscle; This is a spontaneous report from a Pfizer sponsored program COVAX US SUPPORT via a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation; desvenlafaxine succinate monohydrate (PRISTIQ), via an unspecified route of administration from an unspecified date at an unspecified dose for an unspecified indication. The patient medical history and concomitant medications were not reported. The patient previously took venlafaxine hydrochloride (EFFEXOR). Patient was taking EFFEXOR but was switched to PRISTIQ. HCP also increased dose. Since increase in desvenlafaxine succinate monohydrate having pain in left gluteal muscle. Received 1st dose of vaccine and after vaccine left gluteal muscle was hurting. The action taken in response to the event for desvenlafaxine succinate monohydrate was unknown. Outcome of the event was unknown.  No follow up attempts are possible. Information about lot/batch number cannot be requested.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Feeling hot, Peripheral swelling, Pruritus
Clinical narrative: I felt dizzy; arm for itchy; now it's all red; now it's all hot; now it's all  swollen.; This is a spontaneous report from a contactable consumer (patient). A 52-year-old non-pregnant female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number= Unknown) via an unspecified route of administration on 17Feb2021 at 18:00 in left arm as single dose for COVID-19 immunization. Patient had no known allergies. Patient had no other medical history. Other medications (concomitant) in two weeks included estrogen and progesterone. Patient did not receive any other vaccine within four weeks of suspect vaccine. Patient did not have COVID prior vaccination and was not tested for COVID post vaccination. On 06Mar2021 at 12:00 PM, 16 days and 18 hours after first dose of vaccine, patient felt dizzy, arm for itchy and now it's all red, hot and swollen. Patient did not receive any treatment for the events. Outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Oropharyngeal pain, Vaccination site pain
Clinical narrative: Soreness at site of injections; muscle aches; swollen lymph node; sore throat; This is a spontaneous report from a contactable consumer (patient). A 52-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number was not reported) via an unspecified route of administration on 05Mar2021 at 14:45 (at the age of 52-years-old) in the left arm as second dose, single for covid-19 immunization. The patient medical history included asthma and had known allergies with PEN. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: UNKNOWN), via an unspecified route on 14Feb2021 at 15:30 as 1st dose, single dose for COVID-19 immunization. The patient concomitant medications included lifitegrast (XIIDRA) and cannabidiol (CBD OIL). On 05Mar2021 at 22:00, the patient experienced soreness at site of injections, muscle aches, swollen lymph node and sore throat. The patient did not received treatment for events. The outcome of the events was not resolved.  No follow up attempts are possible. Information about lot/batch number cannot been obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: Loss of taste; This is a spontaneous report from a contactable consumer (patient herself). A 41-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on an unspecified date (at the age of 41-years-old) as SINGLE DOSE for covid-19 immunisation. Medical history included known allergies to sulfa. The patients concomitant medications were not reported. The patient previously took Zithromax and experienced drug allergy. The patient did not receive other vaccine in four weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. It was unknown if the patient has been tested for COVID-19 post vaccination. On 05Mar2021 at 07:00, the patient experienced loss of taste and no treatment was received for adverse event. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood cholesterol, Blood test, Physical examination, Prostatic specific antigen, Rash pruritic
Clinical narrative: Itchy rash on my arms and my chest and things, my back and my calves in my leg; This is a spontaneous report from a contactable consumer (patient himself).   This 69-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EM9809), via an unknown route, on 08Feb2021 (at the age of 69-year-old male) at single dose for COVID-19 immunisation. Relevant medical history included indigestion/heart burn. Relevant concomitant medications included pantoprazole taken from an unknown date for indigestion/heart burn, and statin. About 3 to 4 days after he received the first dose he started getting an itchy rash on his arms and his chest and things, his back and his calves in his leg, and it have not gotten away and when he went to get his second dose yesterday and he told them about this symptom, they would not give him the second dose. And he is going to see a dermatologist on 15Mar2021 and he is hoping that she is going be able to tell him, if it's safe to get the second dose or what, he doesn't know where to go from here, they would not give him the dose because of the rash and he is not sure if the dermatologist is going to give him okay to get the second dose or what, he doesn't know if this is coincidence that he got the rash or what. Therapeutic measures taken as result of the events included cortisone cream. In early Feb2021, the patient had his annual physical examination including blood work-up, cholesterol, and PSA but results were not provided. The patient wish he could talk to someone that would tell him that this might be caused by the vaccine or no this is not caused by the vaccine. He realized that not seeing him in personal and stuff is difficult to make that assessment. But he just realized he is just a 'bimbo' here and he might know if he never going get the second vaccine because of the rash, so he is kind of frustrated about it. The patient had not recovered from the events.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Dry mouth, Feeling hot, Illness
Clinical narrative: had a very dry mouth; some swelled and itchy hives on the back of my legs; some swelled and itchy hives on the back of my legs; some swelled and itchy hives on the back of my legs; chills; I was getting sick; hot; clammy; This is a spontaneous report from a contactable consumer (Patient). A 47-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: 6n6199 and Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 01Mar2021 15:45, as single dose for COVID-19 immunization. Patient's medical history included asthma, pneumonia, tuberculosis, whooping Cough and allergy to milk. Concomitant medications include Zyrtec, Magnesium, Calcium all taken for unspecified indications. The patient previously took vaccine for Pneumonia via an unspecified route of administration, administered in left arm, vaccine for tuberculosis and whooping cough via an unspecified route of administration, administered in right arm on 18Feb2021. The patient did not had COVID prior vaccination and was not COVID tested post vaccination. On 01Mar2021 08:00 pm, the patient started experiencing some swelled and itchy hives on back of legs, had very dry mouth since getting it (it's been 5 days). On an unknown date in Mar2021, the patient also began to feel like she was getting sick (but 5 days afterward), began to have chills, then hot and clammy. Therapeutic measures were taken as a result of chills, hot and clammy and patient was treated with Tylenol. The outcome of the events was reported as not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Urticaria
Clinical narrative: had a very dry mouth; some swelled and itchy hives on the back of my legs; some swelled and itchy hives on the back of my legs; some swelled and itchy hives on the back of my legs; chills; I was getting sick; hot; clammy; This is a spontaneous report from a contactable consumer (Patient). A 47-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: 6n6199 and Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 01Mar2021 15:45, as single dose for COVID-19 immunization. Patient's medical history included asthma, pneumonia, tuberculosis, whooping Cough and allergy to milk. Concomitant medications include Zyrtec, Magnesium, Calcium all taken for unspecified indications. The patient previously took vaccine for Pneumonia via an unspecified route of administration, administered in left arm, vaccine for tuberculosis and whooping cough via an unspecified route of administration, administered in right arm on 18Feb2021. The patient did not had COVID prior vaccination and was not COVID tested post vaccination. On 01Mar2021 08:00 pm, the patient started experiencing some swelled and itchy hives on back of legs, had very dry mouth since getting it (it's been 5 days). On an unknown date in Mar2021, the patient also began to feel like she was getting sick (but 5 days afterward), began to have chills, then hot and clammy. Therapeutic measures were taken as a result of chills, hot and clammy and patient was treated with Tylenol. The outcome of the events was reported as not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chest discomfort, Dyspnoea, Mouth swelling
Clinical narrative: my mouth started swelling; chest got heavy; lungs started burning; Short of breath; This is a spontaneous report from a contactable consumer (patient reported herself). A 71-years-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in left arm on 04Mar2021 at 01:30 PM (at the age of 71-years-old), as single dose for covid-19 immunization. The patient medical history included rheumatoid RA, high blood pressure, Thyroid hyper and history of blood clots. The patient concomitant medications were not reported. The patient had known allergies to the following historical medications: Levaquin, Topiramate, Arava, Codeine, Imuran, Iodinated agents, Lipitor, Methotrexate derivatives Mucinex, Nitrofurantoin Monohyd Macro, Prednisone, Sulfasalazine and Celebrex. No other vaccine received in four weeks. On 04Mar2021 at 02:00 AM, few minutes after the vaccination, the patient experienced her mouth started swelling, her chest got heavy, and started with burning of her lungs. She also got very short of breath. She used an inhaler which helped and had used it about 7 times. She stated that she was still having these reactions several time a day. The patient had no Covid prior vaccination. All the events were reported as non-serious. The clinical outcome of the events were not recovered.    No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea 5 times in 24 hours; This is a spontaneous report from a non-contactable other hcp. A 28-years-old female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6199), intramuscular, administered in Left Arm on 04Mar2021 15:30 as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included diabetes mellitus, blood cholesterol increased. Concomitant medications included metformin hydrochloride, sitagliptin (JANUMET [METFORMIN HYDROCHLORIDE, SITAGLIPTIN]), atorvastatin (ATORVASTATIN), dapagliflozin propanediol monohydrate (FARXIGA), fish oil (OMEGA 3 [FISH OIL]). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Mar2021 15:30, (24 hours after receiving vaccine) The patient experienced diarrhea 5 times in 24 hours. No treatment was received for adverse event. The outcome of the event was recovering.  No follow-up attempts are possible. No further information is expected
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: After 10 hours extreme pain left arm bicep; This is a spontaneous report from a contactable other HCP (patient).  A 65-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number: EN6199), via an unspecified route of administration on 05Mar2021 at 02:15 pm (65-year-old at the time of vaccination) on the left arm as a single dose for COVID-19 immunisation. The patient had no known allergy. The Patient's medical history included Type 2 diabetes, prostate cancer 2019 (no signs of cancer 2020). COVID prior vaccination was none. Since the vaccination, patient had not been tested for COVID-19. COVID tested post vaccination was none. The patient's concomitant medications were not reported. On 05Mar2021, at 09:00 pm, the patient experienced extreme pain in the left arm bicep. The patient did not receive any treatment medication for the events. The outcome of the events was unknown.  No follow-up attempts are Possible. No further information is expected
Sex: U
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Body pain, body aches; Painful leg; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number: EL9267), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced some body pain, body aches and painful leg. The patient reported that he had Tylenol and still want to know if he could take two or some. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Malaise
Clinical narrative: Tiredness; headache; muscle pain; chills; joint pain; fever; nausea; feeling unwell; vomiting; This is a spontaneous report from a contactable consumer (patient). A 73-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: not reported) via an unknown route of administration on 03Mar2021 at 13:15 pm as 1ST DOSE, SINGLE for covid-19 immunization. Medical history included none and Concomitant medications in two weeks included Dabigatran etexilate mesilate (PRADAXA).  prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Mar2021 at 08:00 am, the patient experienced tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell and vomiting. No treatment was received for the events. The outcome of the events was not resolved.   No follow-up attempts were possible; information about lot/batch number cannot be obtained.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: Tiredness; headache; muscle pain; chills; joint pain; fever; nausea; feeling unwell; vomiting; This is a spontaneous report from a contactable consumer (patient). A 73-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: not reported) via an unknown route of administration on 03Mar2021 at 13:15 pm as 1ST DOSE, SINGLE for covid-19 immunization. Medical history included none and Concomitant medications in two weeks included Dabigatran etexilate mesilate (PRADAXA).  prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Mar2021 at 08:00 am, the patient experienced tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell and vomiting. No treatment was received for the events. The outcome of the events was not resolved.   No follow-up attempts were possible; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Musculoskeletal stiffness, Pain
Clinical narrative: Moderate pain/ Feeling achy; stiffness in left arm/ stiff neck; small cough; headache; This is a spontaneous report from a contactable consumer. This 57-year-old (non-pregnant) female consumer (patient) reported for herself that she received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: En6202) via an unspecified route of administration into the left arm on 05Mar2021 16:45 (at the age of 57-year-old) as single dose for COVID-19 immunisation. The patient medical history included known allergies to Erythromycin and had breast cancer. Concomitant medications were not reported. On 05Mar2021 at around 20:00, the patient reported of moderate pain and stiffness in left arm. Tender to touch and cannot lift more than a few inches. She was feeling achy, had small cough, headache and stiff neck. Facility type vaccine was a school or student health clinic. No other vaccine in four weeks. No treatments received for the adverse events. No Covid prior vaccination nor Covid tested post vaccination. Outcome was not resolved for all the events.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Taste disorder
Clinical narrative: Metallic taste within 1 hour after injection with abnormal taste for 30 hours; Metallic taste within 1 hour after injection with abnormal taste for 30 hours; This is a spontaneous report from a non-contactable (Patient, self-reported).   A 47-years-old (non pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an intramuscular route, administered in right arm on 05Mar2021 13:45 (at the age of 47-years-old), as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included known allergies to Penicillin and previously took doxycycline hyclate and experienced allergy. Concomitant medications included paracetamol (TYLENOL). Patient did not receive other vaccine in four weeks of vaccination. Patient was not diagnosed with COVID-19, prior vaccination. Patient has not been tested for COVID-19, post vaccination. On 05Mar2021, 14:15, 1 hour after vaccination, the patient experienced metallic taste and  abnormal taste for 30 hours. Patient did not received treatment for adverse events. Outcome of the events was recovering.  No follow up attempts are possible. Information about lot/batch number cannot been obtained.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Muscular weakness, Myalgia
Clinical narrative: bilateral lower extremity muscle "soreness/weakness"; fatigue; mild headache for most of the day (coughing made it worse); bilateral lower extremity muscle "soreness/weakness"; coughing; left arm pain/bilateral arm pain (worse of the left); This is a spontaneous report from a non-contactable physician. A 30-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration was not reported), via an unspecified route of administration administered on arm left on 04Mar2021 at single dose for covid-19 immunisation (At the age of 30-year-old).  Medical history included chronic hives from an unknown date and unknown if ongoing. The patient had known allergies: shellfish from an unknown date and unknown if ongoing. Concomitant medications in two weeks included cetirizine taken for an unspecified indication, start and stop date were not reported. No other vaccine in four weeks. Covid prior to vaccination was unknown and the patient was not covid tested post vaccination. On 04Mar2021, the patient experienced left arm pain (the day of the vaccine)and that day after vaccine the patient had bilateral arm pain (worse of the left), bilateral lower extremity muscle "soreness/weakness", fatigue, mild headache for most of the day (coughing made it worse). No treatment was given for any of event. The outcome for all the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: bilateral lower extremity muscle "soreness/weakness"; fatigue; mild headache for most of the day (coughing made it worse); bilateral lower extremity muscle "soreness/weakness"; coughing; left arm pain/bilateral arm pain (worse of the left); This is a spontaneous report from a non-contactable physician. A 30-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration was not reported), via an unspecified route of administration administered on arm left on 04Mar2021 at single dose for covid-19 immunisation (At the age of 30-year-old).  Medical history included chronic hives from an unknown date and unknown if ongoing. The patient had known allergies: shellfish from an unknown date and unknown if ongoing. Concomitant medications in two weeks included cetirizine taken for an unspecified indication, start and stop date were not reported. No other vaccine in four weeks. Covid prior to vaccination was unknown and the patient was not covid tested post vaccination. On 04Mar2021, the patient experienced left arm pain (the day of the vaccine)and that day after vaccine the patient had bilateral arm pain (worse of the left), bilateral lower extremity muscle "soreness/weakness", fatigue, mild headache for most of the day (coughing made it worse). No treatment was given for any of event. The outcome for all the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Muscle spasms
Clinical narrative: Chills; leg cramps; This is a spontaneous report from a contactable consumer. A patient of unknown age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: not reported) via an unknown route of administration on an unknown date as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, the patient experienced chills and leg cramps after use of the vaccine. The outcome of the events was unknown.  No follow-up attempts were possible; information about lot/batch number cannot been obtained.
Sex: U
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Sinus disorder, Vaccination site pain
Clinical narrative: Injection site soreness; stiff neck and sinus issues; stiff neck and sinus issues; This is a spontaneous report from a contactable consumer or other non-HCP. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced injection site soreness and  stiff neck and sinus issues. The outcome of event was unknown.    No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Throat tightness
Clinical narrative: tightness at the back of the throat; sore arm; This is a spontaneous report from a Pfizer-sponsored program  via a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration was not reported), via an unspecified route of administration on 23Feb2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date in 2021, the patient had adverse events after 1st dose which included tightness at the back of the throat and sore arm. The 1st dose was given on 23Feb21 and 2nd dose would be on 16Mar2021. The patient's first inquiry was about the vaccine if it caused infertility for her granddaughter's sake. The outcome of both the events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Chills, Headache, Pain
Clinical narrative: Chills; temp of 100; headache; body aches; This is a spontaneous report from a sponsored program. A contactable male consumer (patient) reported that, on an unspecified age he received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization at the workplace hospital. The patient medical history and concomitant medications were not reported. 05Mar2021 the patient experienced chills, temp of 100, headache and body aches. It was reported that patient received last vaccine 17days ago wanted to know can you get side effects after the vaccine. Patient yesterday had chills, temp of 100, headache and body aches. The patient underwent lab tests and procedures which included body temperature: 100 on 05Mar2021. The outcome of events was unknown.  There were not any unaddressed medical questions referred or forwarded to Medical Information.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever/fever ranging from 101 F to 102.5 F; This is a spontaneous report from a Pfizer-sponsored Program COVAX support from a contactable consumer (patient)   A female patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown) on 04Mar2021 at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. On 05Mar2021, the day after vaccination the patient experienced fever ranging from 101 F to 102.5 F. At the time of the reporting event outcome was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Ageusia, Anosmia, Chills, Decreased appetite
Clinical narrative: Could barely move arms; Stomach ache; Loss of appetite; Severe hydration; Loss of sense of taste and smell; Loss of sense of taste and smell; Chills; Headache; Exhausted; This is a spontaneous report from a contactable consumer via Pfizer-sponsored program. A 74-year-old female consumer (patient) reported for herself that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection; Batch/Lot Number was not reported) via an unspecified route of administration on 05Mar2021 as a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient historical vaccine included first dose of BNT162B2 (COVID Pfizer vaccine) on 25Jan2021 for COVID-19 immunization and experienced sneeze, lost sense of taste and smell for ten days on 01Feb2021, she had tested positive for Covid-19, felt dizziness, extreme fatigue, stomach ache, really horrific headache on the frontal area, had diarrhea for two days, had checked her temperature and oximeter (92, 91, 09) for ten days. Her appointment for her second dose was put off and she was told to not get the shot until symptoms subside. On 10Feb2021, all COVID-19 signs and symptoms went away except for constant loss of taste and smell. She experienced the events till then. On 05Mar2021, nine hours later after receiving the second dose the patient reported that she could barely move her arms (mobility decreased) and had chills for hours all night. She had headache and she felt that COVID-19 came back. She also had stomach ache, loss of appetite and severe hydration. She mentioned she had no temperature and was so exhausted that she slept all day. She reported all events went away except for loss of sense of taste and smell. She called in to Pfizer because she thought these data could help. There were no unaddressed medical questions referred or forwarded to Medical Information. The outcome for the event ageusia and anosmia was not recovered and for all other events was recovered on Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021269114 Same patient, different dose